Dupont L, Delattre B, Sans Merce M, Poletti P, Boudabbous S
Cancers (Basel). 2024; 16(22).
PMID: 39594807
PMC: 11592662.
DOI: 10.3390/cancers16223852.
Narang M, Singh A, Mahapatra S, Gunjan D, Sharma S, Srivastava D
Abdom Radiol (NY). 2024; 49(10):3528-3539.
PMID: 38900324
DOI: 10.1007/s00261-024-04443-0.
Wang K, Ju L, Song Y, Blair L, Xie K, Liu C
Magn Reson Med. 2024; 92(4):1456-1470.
PMID: 38748853
PMC: 11262991.
DOI: 10.1002/mrm.30134.
Mui A, Lee A, Ng W, Lee V, Vardhanabhuti V, Man S
Phys Imaging Radiat Oncol. 2023; 27:100458.
PMID: 37457666
PMC: 10339040.
DOI: 10.1016/j.phro.2023.100458.
Negi P, Mehta S, Jena A, Rana P
J Med Phys. 2023; 48(1):19-25.
PMID: 37342602
PMC: 10277302.
DOI: 10.4103/jmp.jmp_90_22.
Correlations of tumour permeability parameters with apparent diffusion coefficient in nasopharyngeal carcinoma.
Mui A, Lee A, Ng W, Lee V, Vardhanabhuti V, Man S
Phys Imaging Radiat Oncol. 2022; 24:30-35.
PMID: 36148154
PMC: 9485900.
DOI: 10.1016/j.phro.2022.09.001.
Dynamic Contrast Enhanced Study in Multiparametric Examination of the Prostate-Can We Make Better Use of It?.
Guljas S, Bensic M, Krivdic Dupan Z, Pavlovic O, Krajina V, Pavokovic D
Tomography. 2022; 8(3):1509-1521.
PMID: 35736872
PMC: 9231365.
DOI: 10.3390/tomography8030124.
Dynamic contrast-enhanced MRI predicts PTEN protein expression which can function as a prognostic measure of progression-free survival in NPC patients.
Wu G, Huang W, Xu J, Li W, Wu Y, Yang Q
J Cancer Res Clin Oncol. 2021; 148(7):1771-1780.
PMID: 34398299
DOI: 10.1007/s00432-021-03764-7.
Use of Multiple-Tube Phantom: A Method to Globally Correct Native T1 Relaxation Time Inhomogeneity in Dedicated Molecular Magnetic Resonance Breast Coil.
Negi P, Mehta S, Jena A
J Med Phys. 2021; 46(1):41-46.
PMID: 34267488
PMC: 8240908.
DOI: 10.4103/jmp.JMP_2_20.
Rapid 2D variable flip angle method for accurate and precise T measurements over a wide range of T values.
Lena B, Bos C, Ferrer C, Moonen C, Viergever M, Bartels L
NMR Biomed. 2021; 34(8):e4542.
PMID: 34031938
PMC: 8365751.
DOI: 10.1002/nbm.4542.
Quantitative assessment of acquisition imaging parameters on MRI radiomics features: a prospective anthropomorphic phantom study using a 3D-T2W-TSE sequence for MR-guided-radiotherapy.
Yuan J, Xue C, Lo G, Wong O, Zhou Y, Yu S
Quant Imaging Med Surg. 2021; 11(5):1870-1887.
PMID: 33936971
PMC: 8047358.
DOI: 10.21037/qims-20-865.
Reliability of dynamic contrast-enhanced magnetic resonance imaging data in primary brain tumours: a comparison of Tofts and shutter speed models.
Inglese M, Ordidge K, Honeyfield L, Barwick T, Aboagye E, Waldman A
Neuroradiology. 2019; 61(12):1375-1386.
PMID: 31392385
PMC: 6848046.
DOI: 10.1007/s00234-019-02265-2.
Functional magnetic resonance imaging of head and neck cancer: Performance and potential.
Beltagi A, Elsotouhy A, Own A, Abdelfattah W, Nair K, Vattoth S
Neuroradiol J. 2018; 32(1):36-52.
PMID: 30396315
PMC: 6327365.
DOI: 10.1177/1971400918808546.
Clinical translation of [F]ICMT-11 for measuring chemotherapy-induced caspase 3/7 activation in breast and lung cancer.
Dubash S, Merchant S, Heinzmann K, Mauri F, Lavdas I, Inglese M
Eur J Nucl Med Mol Imaging. 2018; 45(13):2285-2299.
PMID: 30259091
PMC: 6208806.
DOI: 10.1007/s00259-018-4098-9.
Relationship between functional imaging and immunohistochemical markers and prediction of breast cancer subtype: a PET/MRI study.
Incoronato M, Grimaldi A, Cavaliere C, Inglese M, Mirabelli P, Monti S
Eur J Nucl Med Mol Imaging. 2018; 45(10):1680-1693.
PMID: 29696443
DOI: 10.1007/s00259-018-4010-7.
Evaluation of B inhomogeneity effect on DCE-MRI data analysis of brain tumor patients at 3T.
Sengupta A, Gupta R, Singh A
J Transl Med. 2017; 15(1):242.
PMID: 29197390
PMC: 5712076.
DOI: 10.1186/s12967-017-1349-7.
Discrimination between benign and malignant breast lesions using volumetric quantitative dynamic contrast-enhanced MR imaging.
Cheng Z, Wu Z, Shi G, Yi Z, Xie M, Zeng W
Eur Radiol. 2017; 28(3):982-991.
PMID: 28929243
DOI: 10.1007/s00330-017-5050-2.
DCE-MRI for Pre-Treatment Prediction and Post-Treatment Assessment of Treatment Response in Sites of Squamous Cell Carcinoma in the Head and Neck.
King A, Chow S, Yu K, Mo F, Yeung D, Yuan J
PLoS One. 2015; 10(12):e0144770.
PMID: 26657972
PMC: 4684338.
DOI: 10.1371/journal.pone.0144770.
Dynamic Contrast-Enhanced MR Imaging in Head and Neck Cancer: Techniques and Clinical Applications.
Gaddikeri S, Gaddikeri R, Tailor T, Anzai Y
AJNR Am J Neuroradiol. 2015; 37(4):588-95.
PMID: 26427839
PMC: 7960151.
DOI: 10.3174/ajnr.A4458.
Transcatheter embolization therapy in liver cancer: an update of clinical evidences.
Wang Y, De Baere T, Idee J, Ballet S
Chin J Cancer Res. 2015; 27(2):96-121.
PMID: 25937772
PMC: 4409973.
DOI: 10.3978/j.issn.1000-9604.2015.03.03.